TERNS PHARMACEUTICALS INC's ticker is TERN and the CUSIP is 880881107. A total of 46 filers reported holding TERNS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $38,324,249 | -42.5% | 7,619,135 | 0.0% | 0.81% | -32.6% |
| Q2 2023 | $66,667,431 | -26.1% | 7,619,135 | 0.0% | 1.21% | -31.8% |
| Q1 2023 | $90,210,558 | +16.3% | 7,619,135 | 0.0% | 1.77% | +19.3% |
| Q4 2022 | $77,562,794 | +76.0% | 7,619,135 | +1.8% | 1.48% | +81.4% |
| Q3 2022 | $44,064,000 | +368.7% | 7,481,204 | +97.3% | 0.82% | +381.2% |
| Q2 2022 | $9,402,000 | -16.5% | 3,791,204 | 0.0% | 0.17% | -7.1% |
| Q1 2022 | $11,260,000 | -58.0% | 3,791,204 | 0.0% | 0.18% | -47.0% |
| Q4 2021 | $26,804,000 | -32.1% | 3,791,204 | 0.0% | 0.34% | -20.5% |
| Q3 2021 | $39,504,000 | -15.0% | 3,791,204 | 0.0% | 0.43% | -7.7% |
| Q2 2021 | $46,480,000 | -44.3% | 3,791,204 | 0.0% | 0.47% | -39.7% |
| Q1 2021 | $83,406,000 | – | 3,791,204 | – | 0.78% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 970,000 | $8,487,500 | 5.75% |
| VR Adviser, LLC | 2,972,869 | $26,012,604 | 4.16% |
| Vivo Capital, LLC | 6,657,992 | $58,257,430 | 4.02% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,561,835 | $48,666,056 | 2.60% |
| Fairmount Funds Management LLC | 2,040,000 | $17,850,000 | 2.52% |
| Decheng Capital Management III (Cayman), LLC | 714,285 | $6,249,994 | 1.96% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 599,668 | $5,247,095 | 1.62% |
| Orbimed Advisors | 7,619,135 | $66,667,431 | 1.21% |
| CROSSPOINT FINANCIAL, LLC | 12,054 | $105,473 | 1.07% |
| HighVista Strategies LLC | 179,670 | $1,572,113 | 0.72% |